Literature DB >> 17027765

Relative expression of D3 dopamine receptor and alternative splice variant D3nf mRNA in high and low responders to novelty.

Laurel M Pritchard1, Aaron D Logue, Benjamin C Taylor, Rebecca Ahlbrand, Jeffrey A Welge, Yang Tang, Frank R Sharp, Neil M Richtand.   

Abstract

Studies in rodents suggest an important role for the D3 dopamine receptor in regulating locomotor responses to spatial novelty and psychostimulants. The D3 receptor alternatively spliced variant D3nf produces a non-dopamine binding protein that may alter D3 receptor localization by dimerizing with the full-length receptor. In the high responder/low responder (HR/LR) model, the locomotor response to an inescapable, novel spatial environment predicts individual differences in the locomotor and rewarding effects of psychostimulants. We hypothesized that individual differences in D3 receptor expression could contribute to individual differences in the locomotor response to novelty in the HR/LR model. To test this hypothesis, we screened rats for response to a novel spatial environment and analyzed brain tissue for mRNA levels of the D3 receptor and D3nf by real-time RT-PCR. The ratios of D3/D3nf mRNA in prefrontal cortex and substantia nigra/ventral tegmentum were significantly lower in HRs than in LRs. There were no differences in relative expression of D3/D3nf between HRs and LRs in nucleus accumbens. These data further support a role for the D3 dopamine receptor in behavioral responses to novelty and, given the established relationship between novelty and psychostimulant responses, suggest that the D3 receptor may be an important target for assessment of drug abuse vulnerability. Additionally, these findings are consistent with the hypothesis that alternative splicing may contribute to regulation of D3 dopamine receptor function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17027765      PMCID: PMC1815377          DOI: 10.1016/j.brainresbull.2006.06.010

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  41 in total

1.  Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration.

Authors:  P V Piazza; F Rougé-Pont; J M Deminière; M Kharoubi; M Le Moal; H Simon
Journal:  Brain Res       Date:  1991-12-13       Impact factor: 3.252

2.  A novel short isoform of the D3 dopamine receptor generated by alternative splicing in the third cytoplasmic loop.

Authors:  C S Fishburn; D Belleli; C David; S Carmon; S Fuchs
Journal:  J Biol Chem       Date:  1993-03-15       Impact factor: 5.157

3.  On the origin of mRNA encoding the truncated dopamine D3-type receptor D3nf and detection of D3nf-like immunoreactivity in human brain.

Authors:  K Liu; C Bergson; R Levenson; C Schmauss
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

4.  Molecular cloning and characterization of the mouse dopamine D3 receptor gene: an additional intron and an mRNA variant.

Authors:  D Fu; B V Skryabin; J Brosius; N K Robakis
Journal:  DNA Cell Biol       Date:  1995-06       Impact factor: 3.311

5.  Individual locomotor response to novelty predicts selective alterations in D1 and D2 receptors and mRNAs.

Authors:  M S Hooks; J L Juncos; J B Justice; S M Meiergerd; S L Povlock; J O Schenk; P W Kalivas
Journal:  J Neurosci       Date:  1994-10       Impact factor: 6.167

6.  Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia.

Authors:  C Schmauss; V Haroutunian; K L Davis; M Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

7.  Higher and longer stress-induced increase in dopamine concentrations in the nucleus accumbens of animals predisposed to amphetamine self-administration. A microdialysis study.

Authors:  F Rougé-Pont; P V Piazza; M Kharouby; M Le Moal; H Simon
Journal:  Brain Res       Date:  1993-01-29       Impact factor: 3.252

8.  Expression of the D3 dopamine receptor gene and a novel variant transcript generated by alternative splicing in human peripheral blood lymphocytes.

Authors:  Y Nagai; S Ueno; Y Saeki; F Soga; T Yanagihara
Journal:  Biochem Biophys Res Commun       Date:  1993-07-15       Impact factor: 3.575

9.  Novelty-induced increase in dopamine release in the rat prefrontal cortex in vivo: inhibition by diazepam.

Authors:  M G Feenstra; M H Botterblom; J F van Uum
Journal:  Neurosci Lett       Date:  1995-04-14       Impact factor: 3.046

10.  Response to novelty predicts the locomotor and nucleus accumbens dopamine response to cocaine.

Authors:  M S Hooks; G H Jones; A D Smith; D B Neill; J B Justice
Journal:  Synapse       Date:  1991-10       Impact factor: 2.562

View more
  7 in total

1.  Dopaminergic regulation of dopamine D3 and D3nf receptor mRNA expression.

Authors:  Neil M Richtand; Yanhong Liu; Rebecca Ahlbrand; Juliana R Sullivan; Amy Hauck Newman; Robert K McNamara
Journal:  Synapse       Date:  2010-08       Impact factor: 2.562

2.  Neurochemical and behavioral features in genetic absence epilepsy and in acutely induced absence seizures.

Authors:  A S Bazyan; G van Luijtelaar
Journal:  ISRN Neurol       Date:  2013-05-07

3.  Midbrain dopamine receptor availability is inversely associated with novelty-seeking traits in humans.

Authors:  David H Zald; Ronald L Cowan; Patrizia Riccardi; Ronald M Baldwin; M Sib Ansari; Rui Li; Evan S Shelby; Clarence E Smith; Maureen McHugo; Robert M Kessler
Journal:  J Neurosci       Date:  2008-12-31       Impact factor: 6.167

4.  Differential Effect of the Dopamine D3 Agonist (±)-7-Hydroxy-2-(N,N-di-n-propylamino) Tetralin (7-OH-DPAT) on Motor Activity between Adult Wistar and Sprague-Dawley Rats after a Neonatal Ventral Hippocampus Lesion.

Authors:  Sonia Guzmán-Velázquez; Linda Garcés-Ramírez; Gonzalo Flores; Fidel De La Cruz; Sergio R Zamudio
Journal:  Int J Med Chem       Date:  2011-05-24

Review 5.  Maladaptive reward-learning and impulse control disorders in patients with Parkinson's disease: a clinical overview and pathophysiology update.

Authors:  Jee-Young Lee; Beom Seok Jeon
Journal:  J Mov Disord       Date:  2014-10-30

Review 6.  Immunomodulatory Effects Mediated by Dopamine.

Authors:  Rodrigo Arreola; Samantha Alvarez-Herrera; Gilberto Pérez-Sánchez; Enrique Becerril-Villanueva; Carlos Cruz-Fuentes; Enrique Octavio Flores-Gutierrez; María Eugenia Garcés-Alvarez; Dora Luz de la Cruz-Aguilera; Emilio Medina-Rivero; Gabriela Hurtado-Alvarado; Saray Quintero-Fabián; Lenin Pavón
Journal:  J Immunol Res       Date:  2016-10-04       Impact factor: 4.818

7.  Active Reward Processing during Human Sleep: Insights from Sleep-Related Eating Disorder.

Authors:  Lampros Perogamvros; Patrick Baud; Roland Hasler; Claude Robert Cloninger; Sophie Schwartz; Stephen Perrig
Journal:  Front Neurol       Date:  2012-11-27       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.